Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	65.12	34.38	20.82
Graham Fair Price	-59.05	14.71	35.91
PEG	-1947.55	-0.81	-0.04
Price/Book	-7.32	1.51	1.62
Price/Cash Flow	29.32	60.38	46.69
Prices/Earnings	455.76	67.37	12.12
Price/Sales	15.45	9.11	7.89
Price/FCF	29.32	60.38	46.69
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.85	0.74	0.77
Operating Margin	-41.77	0.14	0.23
ROA	-84.39	< 0.005	0.02
ROE	0.03	< 0.005	-83.32
ROIC	0.03	< 0.005	-67.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	0.47
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	7.81	-0.53	-93.21
EPS QOQ	3.07	-0.83	-72.86
FCF QOQ	0.45	-0.28	-37.10
Revenue QOQ	0.14	-0.19	34.85
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	77.95	127.89	64.06
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.35	0.35	-0.04
Quick Ratio	2.55	1.81	-29.25
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	41.36	41.47	0.28
Cash	16.71	16.38	-1.96
Capex	-0.57	-0.61	-6.94
Free Cash Flow	1.44	1.03	-28.13
Revenue	8.52	6.86	-19.49
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.76	1.95	-29.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.64	2.93	78.37
Naive Interpretation	Member

06 - Financial Health · Weak

Rating